We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Patient's Stem Cells Used To Create New Trachea

By LabMedica International staff writers
Posted on 09 Dec 2008
In a revolutionary development, an international medical effort has succeeded in providing a critically ill, 30-year-old Colombian woman with a new tracheal graft. More...
The new organ was constructed by Italian and British scientists, while the reconstructive surgery took place in Spain. A 7-cm long portion of trachea was harvested from a deceased patient, cleansed of all its tissue, and then modified with the woman's own stem cells.

The stem cells were harvested from the woman's own spinal cord, and grown in the laboratory at the University of Bristol (UB; UK). "Surgeons can now start to see and understand the very real potential for adult stem cells and tissue engineering to radically improve their ability to treat patients. We believe this success has proved that we are on the verge of a new age in surgical care,” said UB surgery professor, Dr. Martin Birchall, one of the members of the team that grew the cells.

The next step, for the hospital in Barcelona, Spain, was to send the harvested windpipe to University of Padua (Italy), where a team of researchers, led by Dr. Maria Teresa Conconi, used detergents and a variety of enzymes to remove all existing cells from the trachea. After approximately six weeks, all that was left was a scaffold, strong enough to sustain the implantation of other cells on top of it.

At the same time, Bristol scientists grew the cells in the laboratory, forcing them to develop as new cartilage cells, the type that can usually be found in the windpipe. When the graft was complete, they sent it to Italy again, but this time at the Polytechnic of Milan. There, a bioreactor fused the scaffold and the new cells together, after four days of incubation. It took from March to June 2008 to complete this troublesome task, but, finally, surgeon Dr. Paolo Macchiarini, at the Hospital Clinic (Barcelona, Spain) managed to perform the surgery, offering the patient, who could not use her left lung, a new chance. Now, more than five months later, the transplant is still healthy, and her body shows no signs of rejecting the new organ.

The study was published online November 19, 2008, in the journal The Lancet. "We think this represents a landmark and hope it will unlock the door for a safe and recipient-tailored transplantation of the airway in adults and children,” the authors reported in their study. "We hope that these future patients will no longer suffer the trauma of speech loss, severe shortness of breath, and limited social activities.”

Even more significantly, the procedure helps establish real evidence that new organs can be developed from a patient's stem cells. Moreover, this may lead to a groundbreaking new approach to developing replacement body parts.

Related Links:
University of Bristol
University of Padua
Hospital Clinic, Barcelona


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.